What sectors does ARCH Venture Partners invest in?

With $12B in total AUM, ARCH is one of the largest biotech venture firms globally, creating and funding companies around the most promising scientific breakthroughs.

Typical check size

€4.6M – €46M

Fund size: $3B+ Fund XIII (2024)

Browse similar check sizes →

Portfolio highlights

Alnylam Pharmaceuticals - RNAi therapeutics

GRAIL - multi-cancer early detection

Impinj - IoT/RAIN RFID

Contact

archventure.com

United States

Research with AI

Learn more about ARCH Venture Partners using AI:

Ask ChatGPT Ask Perplexity

Pitch guides

Learn what ARCH Venture Partners and similar investors look for:

Biotech pitch guide AI pitch guide

Ready to start fundraising?

Create your pitch deck with AI, get investor-ready feedback, and find the right investors for your startup.

Get started free

Venture capital

United States

ARCH Venture Partners

Investment focus

Sectors

Biotech

Deeptech

Investment stages

Seed

Series A

Geographic focus

United States

Investment thesis

With $12B in total AUM, ARCH is one of the largest biotech venture firms globally, creating and funding companies around the most promising scientific breakthroughs.